Processing of Clostridium difficile toxins
Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Universität Freiburg, Albertstrasse 25, D-79104 Freiburg, Germany Correspondence Klaus Aktories Klaus.Aktories{at}pharmakol.uni-freiburg.de The pathogenicity of Clostridium difficile depends on the large clostridial glucosylati...
Gespeichert in:
Veröffentlicht in: | Journal of medical microbiology 2008-06, Vol.57 (6), p.690-696 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Universität Freiburg, Albertstrasse 25, D-79104 Freiburg, Germany
Correspondence Klaus Aktories Klaus.Aktories{at}pharmakol.uni-freiburg.de
The pathogenicity of Clostridium difficile depends on the large clostridial glucosylating toxins A and B (TcdA and TcdB). The proteins accomplish their own uptake by a modular structure comprising a catalytic and a binding/translocation domain. Based on a proteolytic processing step solely the catalytic domain reaches the cytosol. Within the cells, the glucosyltransferases inactivate small GTPases by mono- O -glucosylation. Here, a short overview is given regarding latest insights into the intramolecular processing, which is mediated by an intrinsic protease activity. |
---|---|
ISSN: | 0022-2615 1473-5644 |
DOI: | 10.1099/jmm.0.47742-0 |